Synthonics Inc.

Our MCP (metal coordinated pharmaceutical) technology converts cannabis oil into a fine powder which is not an isolate but a chylomicron of CBDA/CBD/CBN

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Blacksburg, VA, US
  • Currency USD
  • Founded June 2006
  • Employees 4
  • Incorporation Type C-corp
  • Website synthonicsinc.com

Company Summary

Synthonics is a biopharmaceutical company that has developed a novel marijuana extraction process that produces 100% cannabinoids without solvents and thus removes the 60% of the unwanted plant materials. More importantly we can convert the CBDA and THCA to CBD and THC. We have also enabled a metallo-CBDA and THCA molecules that we believe will bypass the metabolism of the kidney and have more of the cannabinoid enter into the bloodstream

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free